Anthony Pompliano 🌪|Nov 20, 2026 14:08
Hone Health just raised $228 million.
Last year they blew through $100 million in recurring revenue. The founder, @Saad_Hone, says if things go to plan, they can take the company public in three years.
“Don’t go chase after fads like compounded GLP-1s just for revenue.”
“Longevity care... it’ll be as cheap as primary care.”
His bet is the one thing AI can’t easily replicate: complex, long-term care.
TIMESTAMPS:
0:00 - Investing in AI healthcare:
1:58 - Why online GLP-1 and async clinics are going to zero
6:24 - Hone’s $65 blood test
8:05 - Why longevity care will be as cheap as primary care
13:07 - 3-year IPO path
19:19 - Why US healthcare got pricier
21:32 - Wearables, proactive alerts, and tracking his mom’s heart
30:46 - How AI shifts the biotech bottleneck to clinical trials
34:23 - Peptides
40:05 - Saad at age 44 feeling 27 biologically
43:08 - where to sign up for Hone
Share To
Timeline
HotFlash
APP
X
Telegram
CopyLink